LivaNova Pumps Up its Heart Portfolio with TandemLife Deal
LivaNova said it will pay up to $250 million for TandemLife, a deal that will significantly bolster its cardiac surgery portfolio.

LivaNova said it will pay up to $250 million for TandemLife, a deal that will significantly bolster its cardiac surgery portfolio.
